Sign In
22 Jan 2020 16:40
22 January 2020
Cello Health plc
("Cello" or the "Company")
Block Listing Update
Total Voting Rights
The Company notifies that, since the date of its most recent block listing update, a total of 1,232,928 new ordinary shares of 10p each in the share capital of the Company have been issued and allotted (pursuant to the Company's PSP Option Scheme 2010, its Approved Share Option Plan 2009 and its Unapproved Scheme 2010) and admitted to trading in accordance with the block listing. An update in accordance with Schedule 6 of the AIM Rules for Companies is set out below.
As at today's date, Cello's issued share capital comprises 106,778,473 ordinary shares of 10 pence each ("Ordinary Shares"), of which 453,000 Ordinary Shares are held in treasury. The total number of current voting rights in the Company is therefore 106,325,473 Ordinary Shares, which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Enquires
Cello Health | 020 7812 8460 |
Mark Scott, Chief Executive |
|
Mark Bentley, Group Finance Director |
|
Cenkos Securities | 020 7397 8900 |
Giles Balleny |
|
Harry Hargreaves |
|
Buchanan | 020 7466 5000 |
Mark Court |
|
Jamie Hooper |
|
Sophie Wills |
|
BLOCK LISTING SIX MONTHLY RETURN
Name of applicant: | Cello Health plc | |||
Name of scheme: | PSP Option Scheme 2010, Approved Share Option Plan 2009 and Unapproved Scheme 2010 | |||
Period of return: | From: | 23 May 2019 | To: | 21 January 2020 |
Balance of unallotted securities under scheme(s) from previous return: | 2,918,747 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | - | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | (1,232,928) | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 1,685,819 | |||
Name of contact: | Mark Bentley, Group Finance Director | |||
Telephone number of contact: | 020 7812 8460 | |||
Follow the stocks
